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OBJECTIVES:  Alzheimer’s disease (AD) is the most common form of dementia, the group of 
brain disorders that cause memory loss and decline in mental function over time.  AD is the third 
most expensive disease in the nation, after heart disease and cancer.  Average lifetime costs per 
patient are $174,000 with annual estimates of $80 to $100 billion dollars in health care expenses 
and lost wages for the AD patient or their family caregivers.  This study was designed to describe 
social policy and its affects on the eligibility and determination of benefits for two community-
dwelling patients with AD and their caregivers in Southwestern Pennsylvania.  The cases were 
purposefully selected to represent early age and late age of the onset disease and variability in 
service. METHODS:  Secondary data analysis was conducted from data drawn from a previous 
study, “The Process of Medication Taking,” (J. Erlen, PI).  Data for the current analysis included 
participant observations, interactive unstructured informal interviews, open-ended formal 
interviews and case description.  Constant comparative analysis was used to determine 
similarities and differences between cases.  RESULTS:  Family caregivers aim to achieve a 
stable community dwelling status for the AD patient.  To achieve this objective, the family and 
patient’s traverse a pathway of social care needs that include.  Accessing social services, 
cultivating a social support network, maintaining continuity of care, and managing the 
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 health care needs beyond the diagnosis of AD.  Barriers to achieving the objective of a stable 
community dwelling status for the patient are social service eligibility, location to eligible 
services and inadequate support by family and friends.  PUBLIC HEALTH SIGNIFICANCE:  
The number of AD patients has doubled since 1980 and is expected to continue to expand to 11.3 
to 16 million people by the year 2050.  Furthermore, much of the long-term care is being 
provided by the family caregivers.  Programs such as Medicare, Medicaid and Social Security 
Disability Insurance do not cover all of the needs and financial obligations for patients and their 
families.  Even after these public programs, families continue to remain financially responsible 
for the care of their family member.  Therefore, policy focused on evaluating AD on the basis of 
diagnosis rather than social policy eligibility criteria, such as age, may be warranted to provide 
optimal benefits for patients and family caregivers. 
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 1. INTRODUCTION 
1.1. BACKGROUND & SIGNIFICANCE 
 Alzheimer’s disease (AD) is a progressive brain disorder that gradually destroys a 
person’s memory and ability to learn, reason, make judgments, communicate and carry out daily 
activities. As AD progresses, individuals may also experience changes in personality and 
behavior, such as anxiety, suspiciousness or agitation, as well as delusions or hallucinations.  AD 
is the most common form of dementia, a group of conditions that all gradually destroy brain cells 
and lead to progressive decline in mental function.  AD advances at widely different rates. The 
duration of the illness may vary from 3 to 20 years.1 The areas of the brain that control memory 
and thinking skills are affected first, but as the disease progresses, cells die in other regions of 
the brain. Eventually, the person with AD will need complete care. If the individual has no other 
serious illness, the loss of brain function itself will eventually cause death. 2  An estimated 4.5 
million Americans have AD. The number of Americans with AD has more than doubled since 
1980.3  The number of Americans with AD will continue to grow – by 2050 the number of 
individuals with AD could range from 11.3 million to 16 million.3   
 Increasing age is the greatest risk factor for AD. One in 10 individuals over 65 and nearly 
half of those over 85 are affected.4 Rare, inherited forms of AD can strike individuals as early as 
their 30s and 40s.5  Symptoms of AD appear, in most cases, after the age of 65, also known as 
late-onset.  However, approximately 5% of all Alzheimer’s disease cases have an early-onset 
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 (before the age of 65).6, 7  Of the 5% of the population diagnosed with early onset AD, 61% had a 
positive family history for the disease and 13% had affected individuals in at least three 
generations.6, 7  People with AD will live an average of eight years and as many as 20 years or 
more from the onset of symptoms as estimated by relatives. From the time of diagnosis, people 
with AD survive about half as long as those of similar age without dementia. Average survival 
time is affected by age at diagnosis and severity of other medical conditions.8 
1.2. STATEMENT OF THE PROBLEM 
 AD is the 3rd most expensive disease in the nation, after heart disease and cancer, with an 
average lifetime cost per patient of $174,000.9  Annually, an estimated $80 to $100 billion 
dollars are spent on health care expenses or lost in wages for the person with AD or their 
caregivers.10  Long-term care which includes family caregiving is part of the total health care 
expense for Alzheimer’s patients and their families.11  Of these, long-term care and family 
caregiving costs are considered the most important determinants of total cost.  Increases in costs 
are due to disease severity and decline in activities of daily living (ADLs).  Caring for patients at 
home with mild to moderate forms of AD increases indirect costs compared to those being cared 
for in nursing homes.12  As in the past, the current trend is for patients to remain living in the 
community and typically with the caregiver.11  Costs of service is important to AD economics 
because informal caregiving costs can shift to formal caregiving costs when the family caregiver 
is no longer able to provide care for the patient.13, 14 
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 1.3. PURPOSE OF THE STUDY 
 The purpose of the study is to examine social policy as it affects the eligibility and 
determination of benefits for community-dwelling (at home) patients with Alzheimer’s disease 
and their caregivers in Southwestern Pennsylvania.  An in-depth examination of social services 
and economic resources available to two patients with Alzheimer’s disease and their caregivers 
will be analyzed.  Specifically, the study will describe (1) social policy that affects patients with 
Alzheimer’s disease and their family caregivers, (2) eligibility criteria for available services, and 
(3) the impact social policy has on the receipt of benefits for patients and family caregivers.  No 
prior study has described the impact of social policy on the receipt of benefits to AD patients or 
their family caregivers in Southwestern Pennsylvania.  I will describe these social policies and 
the affects they have on the eligibility and receipt of social services and benefits to AD patients 
and their caregivers. 
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 2. METHODS 
2.1. STUDY DESIGN 
 Case analysis using qualitative description15-17 of de-identified data from the original 
study funded by the Alzheimer’s Association entitled "The Process of Medication Taking" (IRB 
#0309058, Judith Erlen, PI) will be performed by reanalyzing the original data set, in whole or 
part, using qualitative case comparison.  Case analysis using qualitative description will be 
utilized to provide in-depth study and comparison of social policy surrounding AD benefits 
organized around the patient-caregiver experience.15-17 This study proposes to identify the social 
policy regarding AD benefits for patients and family caregivers.  The analysis will focus on the 
social policy specifically eligibility, availability and equality of resources to AD patients and 
their family caregivers.  Constant comparative analysis18 is used to identify similarities (or 
differences) in social services and economic resources available for Alzheimer's disease patients 
and their informal (family) caregivers.  Analysis of social policy will evolve around the 
eligibility of the patients and family caregivers regarding access to social services and care.  In 
addition, the level of benefits by policy will be compared to the actual benefits received by the 
patients and family caregivers. 
 Data for this study will be obtained from research study data files. These data were 
previously obtained from multiple sources including participant observations, interactive 
unstructured informal interviews, open-ended formal interviews, and case description.  
 4 
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2.1.1. SAMPLE AND SETTING 
Comparative cases of two (2) community-dwelling patients and their family caregivers 
were purposively selected from the the original study funded by the Alzheimer’s Association 
entitled "The Process of Medication Taking" (IRB #0309058, Judith Erlen, PI).  Table 1 provides 
the complete demographics of the patient sample.  Purposive sampling was chosen to optimize 
the dichotomy and diversity between early-onset and late-onset Alzheimer’s disease.15, 16  Polar 
cases are used to illustrate how differing situations can produce common outcomes.16 In addition, 
the sample was selected for divergent representations of social services, caregiving and access to 
care.  Furthermore, the “Mini-Mental State” examination, a cognitive mental status 
examination,19 for each of these patients represents additional similarities between cases.  
Although the MMSE is similar for these participants, their ability to perform Activities of Daily 
Living (ADLs) and Instrumental Activities of Daily (IADLs) living vary.  Table 2 includes some 
of the participants’ ability to perform IADLs and Table 3 provides the ADLs.  Table 4 provides 
complete demographics of the caregiver sample.   
Table 1.   Patient Demographics 
 Early-onset Patient Late-onset Patient 
Age 51 76 
MMSE19 3 6 
Gender Female Male 
Race Caucasian Caucasian 
Marital Status Married Widowed 
Education Masters’ degree High school diploma 
Primary Caregivers (s) Spouse Adult daughters (2) 
 Table 2.   Instrumental Activities of Daily Living for AD Participants 
Instrumental Activities of Daily Living 
(IADLs) 
Early-onset Patient Late-onset Patient 
Do you use the telephone? completely unable to use the telephone without help including looking up numbers and dialing 
with some help 
(need someone to help you or go with 
you when traveling) 
with some help (need someone to help you or 
go with you when traveling) Do you get to places out of walking distance? 
with some help 
(someone goes with you on all shopping 
trips) 
Do you go shopping for groceries or clothes? completely unable to do any shopping 
Do you prepare your own meals? with some help 
(can prepare some things but unable to 
cook full meals yourself) 
no opportunity to prepare meals and could 
not do so 
Do you do your housework? with some help 
(can do light housework but need help 
with heavy work) 
no opportunity to do housework and could 
not do so 
Do you take your own medication? with some help 
(take medicine if someone prepares it for 
you and/or reminds you to take it) 
with some help 
(take medicine if someone prepares it for you 
and/or reminds you to take it) 
Do you handle your own money? Complete unable to handle money 
 
no opportunity to handle own money and 
could not do so 
 6 
  7 
Table 3.   Activities of Daily Living for AD Participants 
 
Activities of Daily Living (ADLs) Early-onset Patient Late-onset Patient 
Do you eat? without help 
(able to feed yourself completely) 
without help 
(able to feed yourself completely) 
Do you dress yourself? without help 
(able to pick out clothes, dress and 
undress yourself) 
with some help 
Do you take care of your own personal 
appearance, for example, combing your hair 
and (for men) shaving? 
without help with some help 
Do you walk? without any help or aids (except from a 
cane) 
without any help or aids (except from a cane) 
Do you get in and out of bed? without any help or aids without any help or aids 
Do you take a bath or shower? without help with some help 
(need help getting in and out of the tub, or 
need special attachments on the tub) 
Do you ever have trouble getting to the 
bathroom on time? 
No No 
Is there someone who helps you with such 
things as shopping, housework, bathing, 
dressing and getting around? 
Yes Yes 
 Table 4.   Caregiver Demographics 
 
Early-onset Caregiver
(Husband) 
Late-onset Caregiver 
(Daughter 1) 
Late-onset Caregiver
(Daughter 2) 
Age 59 35 41 
Gender Male Female Female 
Race Caucasian Caucasian Caucasian 
Education Master’s degree Associate’s degree High school diploma
Employment Status Full-time Full-time Full-time 
2.2. DATA DRAWN FROM PREVIOUS STUDY 
 The data for this study are drawn from a previous project, “The Process of Medication 
Taking” (IRB #0309058 Judith Erlen, P.I.), a qualitative study funded by the Alzheimer’s 
Association, to examine the process of medication taking among persons with AD who live in 
the community.  A purposive sample of 17 patients with AD and their family caregivers were 
recruited from the Alzheimer’s disease Research Center (ADRC) and community agencies 
serving the elderly. The researchers observed and audio-taped the preparation of daily 
medications and the taking of those medications on one to three occasions in each patient’s 
home. Brief interviews were conducted with the caregivers after each observation. An in-depth 
interview was conducted with the caregiver after the final observation. Brief interviews were also 
conducted with the patient, as appropriate, at the end of each observation. The field notes, 
observations, and the interviews were transcribed verbatim. Data for analysis consists of the 
transcriptions and descriptive data from the MMSE19 and Caregiver Vigilence20 scale and 
participant profile. 
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 2.3. DATA MANAGEMENT AND ANALYSIS 
Textual files were entered into ATLAS.TI version 5.0 (Scientific Software Development, 
Berlin, Germany) for organization and data management.  Each file was labeled with unique 
identifiers and data type (i.e. Interview data, observation, researcher debriefing notes). 
 The qualitative data analysis began with a thorough read of all textual documents to 
obtain a sense of the case story.  After this initial read, guided by the research questions themes 
were identified and coded.21  Initially, types of caregivers and caregiving (family/outside the 
family) and financial assistance/support occurred repeatedly in the coding.  A deeper review led 
to identifying different aspects of support, both financial and social services that contribute to 
access of care and services.  Definitions were applied to each thematic code for consistent 
application to the remaining textual documents.  The comparison of data within and between 
cases led to the sequencing of common and recurring information into themes, which were then 
mapped.  Analytic memos were recorded to detail thoughts, incorporate social policy, and 
establish consistency. 
 Analysis meetings with a faculty mentor (MBH) expert in qualitative methods occurred 
monthly then weekly, at five time points during the analysis process to review themes, analysis, 
and the development of a model for rigor.22, 23  The mentor provided guidance in coding and 
oversight of the analytic process to provide auditability and fittingness as findings were validated 
and applicable.22-24  In addition, the examination of Death in Slow Motion25, a personal account 
of the struggles of caring for an elderly parent with AD, provided confirmability and 
transferability of this data.22-24 
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 2.4. LIMITATIONS 
There are several limitations to this study.  The results of the study are not transferable to 
all Alzheimer’s disease patients and their family caregivers due to the fact that two case studies 
were examined, an late-onset case and an early-onset case.  As such, this study serves as an 
illustrative exemplar of current policy and services for future examination of applicability to the 
larger population of community-dwelling AD patients.  In addition, each case was located in 
differing settings, an urban county and a rural county, in Southwestern Pennsylvania.  
Examination of cases in a suburban setting and additional states is needed to further explore the 
impact of location.  The fact that this is a secondary data analysis limits access to the 
participants, particularly for questions or additional data collection regarding the phenomena of 
interest.26-29  One of the biggest limitations is that social policy and service access were not the 
main focus of the original (parent) study. 
2.5. HUMAN RIGHTS PROTECTION 
A copy of the research protocol for “The Impact of Social Policy on Alzheimer’s Disease 
Patients and their Family Caregivers” (IRB #0607055, D. DiVirgilio-Thomas, PI) was submitted 
to and approved by the University of Pittsburgh Institutional Review Board (IRB) for Human 
Subject Research.  This IRB serves as the IRB for record for the University of Pittsburgh, 
Graduate School of Public Health.  The principal investigator outlined the purpose of the study.  
There were no known risks to the study.  (Appendix A.) 
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 3. ALZHEIMER’S DISEASE OVERVIEW 
Alzheimer’s disease is the most common cause of dementia in older adults.30  Dementia 
is a term used to describe the group of brain disorders that cause memory loss and the decline in 
mental function that occurs over time.1  AD is the most common form of “primary dementia.”  
Primary dementia is defined as dementia that is caused by changes in the brain that are not the 
result of another disorder such as cerebral thrombosis.1  AD can often be confused with the 
normal aging process.  In addition, there are two forms of AD, sporadic and familial.  The 
familial type of AD is genetically predisposed resulting in family history of the disease.  
Whereas, the sporadic type of AD does not appear to have any genetic links for developing AD.1 
The most common early symptom of AD is short term memory loss.1, 31  As this disease 
progresses, symptoms tend to extend over the same general stages.  Stages of the disease range 
from mild to severe.  Figure 11, 31, 32 represents the percentage of the United States population 
with AD by the severity of the disease.  Symptoms span from simple and often fluctuating 
forgetfulness to deterioration of musculature and mobility in the later, more severe stages of 
disease.1, 31  Those persons in the mild stage of AD appear healthy but tend to become less 
energetic or spontaneous.  In addition, it often takes time for them to make ‘sense’ of the world 
around them.  There are changes in their behavior but these changes may go unnoticed by family 
members due to the subtleties of the changes.1, 32 
 
 11 
 n=4.5 million
Moderate
31%
Severe
21%
Mild
48%
 
Figure 1.   AD Population in the United States by Severity of Disease 
 
In the moderate stage of the disease, these persons may continue to perform their daily 
activities independently but may begin to recognize changes in themselves or the severity of the 
symptoms.  It is at this stage, they may also need assistance with more complex activities.  
Furthermore, the processes occurring in the brain begin to worsen causing greater damage in turn 
causing issues with language control, reasoning, sensory processing and thought.1, 31 
In the final stage, the severe stage of the disease, the person will no longer be able to 
function without the assistance of others.  The damage to the brains nerve cells will be 
widespread.  It is at this stage when full time care is required.  It is also at this stage when many 
individuals may become bedridden for long periods of time and often die from other acute 
illnesses.1, 31 
Alzheimer’s disease affects an estimated 4.5 million Americans.1, 3, 30, 33  Of those 4.5 
million affected with AD, 0.3 million (7%) are between the ages of 65 to 74, 2.4 million (53%) 
between the ages of 75 to 84 and 1.8 million (40%) 85 years and older.1, 3  Figure 21, 31, 32 
represents the percentage of the United States population by percentage diagnosed with late-
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 onset Alzheimer’s disease.  By the year 2050, Alzheimer’s disease could affect an estimated 11.3 
million to 16 million individuals.1, 3, 34  Prevalence of AD in the United States are estimated to 
increase as the elderly population continues to grow.  In addition, as the elderly population 
continues to grow, the distribution by age of the disease will also shift.  This shift in age is the 
result of the aging of the “baby boomer” generation.3, 35 
n=4.5 million
65-74 years
7%
75-84 years
53%
85 years and 
older
40%
 
Figure 2.   Age of US population diagnosed with AD 
 
Common risk facts for AD are age, family history and the presence of the apolipoprotein 
E ε4 allele.30, 31  AD is commonly associated with the elderly, 22% of people over age 65,4, 33, 34 
46% of people over age 7534 and 31% of people over age 854, 33, 34 are affected, however, 
individuals in their early 30’s and 40’s can be diagnosed with rare, inherited forms of the 
disease.5, 33  Women are at greater risk for the disease due to longer greater life expectancy.36, 37  
In fact, two-thirds of the elderly population diagnosed with AD are women.34, 38 
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 3.1. EARLY-ONSET ALZHEIMER’S DISEASE 
The most common cause of early-onset dementia is Alzheimer’s disease.34  Early onset 
Alzheimer’s disease is defined or limited to onset prior to or younger than age 65 when the 
appearance of symptoms first begin.35  It is difficult to diagnose early-onset AD in individuals.39, 
40  Advanced brain imaging and improvements in neuropsychological testing have improved 
diagnosis of Alzheimer’s disease to within 90% accuracy.34  Younger age, healthy appearance 
and stress contribute to the inability to properly diagnose AD.39, 40  In addition, inaccurate 
diagnosis of depression or other psychiatric illness does not result in the diagnosis of AD.39  
Furthermore, when AD symptoms have been identified in an individual, different health care 
professionals may provide conflicting diagnoses.39, 41  Early onset AD patients are likely to be 
misdiagnosed more often than late-onset AD patients, have dementias other than AD, and/or 
have treatable or preventable etiologies.36  Frustration levels increase for patients and family 
members as a result of their experience with and treatment by medical professionals, in addition 
to the extended delay in reaching a diagnosis.  Further frustrations result from the prevalence of 
atypical dementias associated with this younger age group.34 
Young onset dementia is frequently familial.  Prior to the age of 40, dementia is rare.  
Early onset AD may begin to manifest beginning in the fourth decade of life.37  Early onset AD 
accounts for 5% of all Alzheimer’s cases.  Familial AD accounts for 61% of patients diagnosed 
with early onset AD.  In addition, 13% of those affected with familial AD occurred in at least 
three generations.  A prevalence rate of 35-41.2 per 100,000 persons at risk for early onset AD 
has been reported.38, 40 
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 The progression of early-onset dementia (EOD) is quicker than in late-onset dementia 
(LOD).42, 43  In addition, the severity of impairment of those diagnosed with EOD may be higher.  
Life expectancy of EOD patients compared to those with LOD is significantly reduced.42, 43  It is 
believed that diagnosis of early-onset dementia has three distinct elements:  “(a) it may identify a 
treatable cause (more likely in younger people); (b) there may be time for appropriate 
management of legal and personal affairs; and (c) it may prepare carers and give access to early 
support.”39, p240.  Since the diagnosis of Alzheimer’s disease is rare and difficult, general 
practitioners are less likely to make a diagnosis of AD in those adults under the age of 65. 39 
Patients diagnosed with early-onset dementia are in a dynamic and particularly 
challenging situation.  It is believed all people diagnosed with Alzheimer’s disease maintain 
some insight about the progress of the disease, but may fluctuate at different times throughout 
the disease.  It is also believed that younger people are more cognizant about the impact the 
disease has upon themselves, and their families.40, 43  It is difficult for people in their forties and 
fifties, at the height of their careers, saving for their retirements, to fathom being diagnosed with 
early-onset dementia, specifically Alzheimer’s disease.  Many of those diagnosed with the 
disease are beginning to pay for or saving for their children’s college educations.  While some 
are able to remain working, limiting their responsibilities, others must stop working completely 
causing financial hardship for their families.  It is in the workplace where most symptoms are 
first recognized.  Tasks become difficult to complete, directions are challenging to follow or 
angry outbursts occur at co-workers, which are atypical of the person.34 
They continue to maintain relationships with ageing parents, spouses and children.  Many 
ageing parents of AD children find it difficult to see their child with Alzheimer’s disease.39  The 
spouse experiences some level of personal upheaval, typically on an emotional level and on a 
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 practical level.  Spouses experience changes in role, responsibility and sexual relationships.39  
Comparisons have been made between children of EOD patients and those with mental health 
problems or degenerative disease.  The difference, however, is that EOD presents several factors 
such as changes in personality traits, progressive deterioration, terminality of condition and a 
loss of role model.  Early-onset dementia emote powerful reactions in children of those affected 
by the disease.  They may become frightened by the disease, by the unexplained behavior 
changes, leading to withdrawal emotionally, socially and often from the informal caretaking 
responsibilities of their parent.39 
We live in a society that highly values personal independence, which includes our ability 
to provide and care for ourselves and loved ones.  Dependence is an attack on our identity, our 
personhood.  There is some expectation of dependency as we age which is often considered 
normal or “on-time.”  However, for those who are diagnosed with early-onset dementias such as 
Alzheimer’s disease, dependency is unexpected, difficult and adds additional stress for all of 
those people involved.34 
The diagnosis of Alzheimer’s disease is typically shocking or unbelievable to those who 
receive it, even though they may have had concerns that something was wrong.  These feelings 
are intensified for younger people diagnosed with EOD because it is “unexpected and rare.”39 
p243.  Many EOD patients experience feelings such as fear, grief, loss, frustration, loss of control, 
embarrassment, insecurity and isolation.39  It is has been reported many of these reactions are the 
same or similar to those people coping with chronic degenerative conditions and/or terminal 
illness, not exclusive of the elderly.39 
High levels of distress occur in early-onset dementia patients.  This high level of distress 
is due to the rapid decline in their condition.  The acknowledgment of coming to terms with EOD 
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 can be traumatic and terrifying especially when dealing with the “erosion of the essence of self, a 
form of ‘decay from within.’”39 p243.  Memory loss in the elderly is a somewhat anticipated event.  
However, for EOD patients, the diagnosis comes unexpectedly.  This diagnosis changes a young 
person’s life expectations greatly.  Age appropriate activities such as employment, family 
caregiving, domestic activities and driving tend to cease.  This illness essentially becomes 
terminal for a young person.39 
3.2. LATE-ONSET ALZHEIMER’S DISEASE 
The progressive degenerative disease that affects cognition, behavior and the ability to 
perform activities of daily living, known as Alzheimer’s disease (AD), is a common disorder that 
affects a larger portion of the elderly population.35, 44  Estimates range from 5.7% to 10% of 
those aged 65 to 85 and 25% to 45% of those aged 85 years and older diagnosed with AD in the 
United States population.32  Alzheimer’s disease is the most common form of dementia 
accounting for 50% to 60% of all documented cases.32, 44  Associated with significant mortality, 
Alzheimer’s disease is the fourth leading cause of death for those persons aged 65 years and 
older.8, 32 
Difficulty in learning and retaining new information, increasing problems with affect 
calculation, visuospatial skills, performance of purposeful acts, and language characterize 
Alzheimer’s disease.  Four hallmarks of Alzheimer’s disease are amnesia, apraxia, agnosia, and 
aphasia making AD one of the most feared diseases by the aging population.45-47  Risk factors for 
AD include aging; family history; presence of APOE4 allele (apolipoprotein ε genotype), lower 
education and gender.35, 46, 48  Estimates of the elderly population in the United States suggest the 
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 incidence of AD doubles every 5 years of age from 1% to 2% at age 60 to more that 40% at age 
85.36, 37 
There are indications that misdiagnosis and delayed detection of AD are common.  This 
suggests that the actual incidence and prevalence rates of AD may in fact be much higher than 
reported.41  Reports of 30% or less of patients with symptoms consistent with AD have an initial 
diagnosis of Alzheimer’s disease.32  Many of these symptoms, which are similar to non-AD 
types of dementia such as normal aging, depression, stroke and Parkinson disease, are often 
confused.  Subtle early signs of Alzheimer’s disease and gradual onset of symptoms cause a 
delay in diagnosis of AD until later in the course of the disease.32, 48 
Age-related memory decline occurs as the normal aging brain undergoes changes in 
structure and function.  These changes are extreme in persons with Alzheimer’s disease.  
Alzheimer’s disease is predictable; however, the disease progression rate is not.  This 
progressive decline, a predictable course, leads to declines in function and behavior that lead to 
loss of independence and eventual death.  Loss of memory and other cognitive functions 
characterize the early stage of the disease.35, 44, 46-49  A progressive decline in the activities of 
daily living (ADLs) follows.48, 49  Behavioral changes or psychiatric symptoms appear.  
Utilization of resources of medical care increases which include nursing home placement.50  
There is often an eventual need for full-time assisted living or nursing home care before death.32, 
44, 47  These changes affect not only the patient but also the caregiver, who is often burdened 
emotionally, physically, and financially.41  Consequently, the health care system is required to 
provide care for patients with AD as well as for caregivers.41 
Rapid decline of cognitive function averages annually 9 to 11 point on the cognitive 
subscale of the Alzheimer’s Disease Assessment Scale.32  The decline is reported at its slowest 
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 during the mild to moderate stages of AD and most rapid during the moderate stage.  Patients 
diagnosed with mild to moderate AD exhibit rapid decline within 2 years if left untreated.42, 51  
Cognitive abilities are completely lost and are inaccessible in the severe stages of the disease.44, 
46  The rate of cognitive, functional and behavioral decline is highly variable in Alzheimer’s 
disease and is not a feature of normal aging. 41 
Alzheimer’s disease patients experience a loss of interest in life.  This comes with 
changes in personality, including distressing social withdrawal, uninhibited behavior and 
psychosis.47, 49  AD manifests behavioral and psychiatric disturbances.  Increasing evidence 
suggest that these symptoms are associated with disease severity.  Studies have shown that 
approximately 80% of patients exhibit behavioral and psychological symptoms at some time 
during their course trajectory.52  These symptoms manifest themselves as personality changes, 
irritability, anxiety and depression in the early stages.  Increases in neuropsychiatric disturbances 
such as agitation, anxiety, restlessness, depression, day-night orientation, disinhibition, delusions 
and hallucinations occur in the moderate to severe stages of AD.44, 47, 49  Agitation manifests 
itself as yelling, screaming, physical abuse of carers, restlessness and swearing.43  A major 
source of caregiver stress and a main contributor to the decision to institutionalize an AD patient 
are these behavioral and psychiatric symptoms.52 
The patient’s loss of independent living is contributed by declining cognition and 
functional abilities.  Early in the course of AD, many patients experience a unique feature of the 
disease, the loss of awareness of this deficit.44, 47  Emergence of feelings of denial, confusion, 
fear and guilt in the patient progress natural with the disease until cognitive loss is sufficient to 
leave the patients unaware of their condition.44, 47  The patient will lose most abilities to think, 
move, speak or perceive until ultimately death occurs.41 
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 4. SOCIAL POLICY OVERVIEW 
Dr. Alois Alzheimer diagnosed the first known case in a 51 year old patient by the name 
of Mrs. Auguste Deter in 1906.  It is interesting therefore that Alzheimer’s disease has become 
almost exclusively associated with aging.  Because Alzheimer’s disease is associated with aging, 
social policy focuses primarily on assisting those individuals aged 65 and older diagnosed with 
this disease.  Unfortunately, for those individuals under the age of 65, this presents difficulties in 
accessing assistance both financially and psycho-socially.  A range of public programs are 
available in the United States primarily geared toward the elderly.  The major programs available 
to AD patients and their families include Medicare, Medicaid and Social Security Disability 
Insurance (SSDI).  Estimated costs of formal and informal care annual in the United States for 
AD patient’s care is $100 billion with an average per person lifetime cost of $174,000.1, 32, 47, 48, 
52, 53  Medicare, Medicaid and Social Security Disability Insurance (SSDI) are not, however, 
deemed adequate to cover all of the financial obligations and needs of those with AD and their 
families.44  Medicare, the United States health insurance program for seniors, spends on average 
70% more for Alzheimer’s disease patients than those with other chronic conditions such as heart 
disease, cancer or diabetes.47  It does not however, cover long-term care, which is most needed.  
Many families and patients primary needs are for social services such caregiving services and 
respite 11, 33, 49.  Even after private insurance and public programs, families of AD patients 
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 continue to remain financially responsible for care needs.  The bulk of the cost of these home-
dwelling patients falls upon these family caregivers.1, 11, 14, 44, 45, 48, 54 
The United States cost of Alzheimer’s disease care is estimated to be at least $100 billion 
in direct and indirect annual costs, ranking third after heart disease and cancer.1, 32, 52, 53  Direct 
medical costs, such as medications, physician visits, hospitalizations, and nursing home costs; 
direct nonmedical costs such as daycare and other social services; and indirect cost such as the 
time caregivers spend with patient and associated loss of productivity in the work place are all 
associated with the cost of Alzheimer’s disease.  Alzheimer’s disease costs American business 
$61 billion a year.  Of that figure, $24.6 billion covers Alzheimer health care and $36.5 billion 
covers costs related to caregivers of individuals with Alzheimer’s, including lost productivity, 
absenteeism and worker replacement.1, 11, 32  In addition, the progression of AD is associated with 
increasing costs, such that the cost of caring for patients with AD increases with increasing 
severity of the disease.  Increasing disease severity also changes the cost determinants.  Indirect 
cost often exceeds direct cost through out the early course of the disease because of home care.  
However, with progression of the disease to more severe stages, institutional care is required 
increasing the direct costs of care and shifting the cost burden to society from the caregivers.  
The health care systems incur considerable costs, which include residential care, day care, 
hospital services, diagnostic tests, monitoring or treating adverse events and outpatient visits.52 
Seven out of 10 Alzheimer’s disease patients are living at home where family and friends 
provide almost 75 percent of their care.11, 14, 45, 48, 49, 54, 55 The remainder is “paid’ care costing an 
average of $19,000 per year.1  This ‘informal’ caregiving contributes the services essential for 
the functionally disabled to sustain the long-term care they require.  Statistically, one out of five 
functionally disabled elders end up in nursing homes to meet their long-term care 
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 requirements.11, 14, 45  The remaining four out of five are able to meet their long-term care needs 
and continue living in their communities as a result of the care they receive from their family and 
friends.11, 14, 46, 54  The vast majority of this ‘informal’ caregiving is provided by the middle-aged 
adult daughter or the daughter-in-law.  As a result of labor force trends, these typical ‘caregivers’ 
are being shifted into the workforce leaving a gap in the need for caregivers.11, 45, 46  These 
women are also often parents of minor children, thus earning them the ‘sandwich’ label. 
The financial cost of care for AD patients begins at diagnosis with the annual costs 
increasing from diagnosis to death.  Alzheimer’s disease patients who have their diagnosis 
recorded on medical claims records have approximately twice the annual expenditures of those 
with AD but without their diagnosis recorded on medical claims records.11, 14, 49, 55, 56  Families, 
the primary sources of care giving, are responsible for up to 50% of the costs for care of their 
loved ones with AD.11, 14, 47-49, 55  In addition, increasing levels of dependency by the affected AD 
patient increases the cost of care an additional 25%.11, 14, 44  Costs for a dementia patient are 
twice as much as that of a non-dementia patient.47, 49  Remaining at home is the desired goal of 
many patients and caregivers but can only be done so with support and assistance and at a cost.44, 
45, 47, 55  As caregivers expend personal and economic resources, there is an increased likelihood 
that the patient will end up institutionalized.  For many caregivers, this internal tension between 
caring for the AD patient and their own duty to keep the patient at home ultimately ends in 
asking for help in both caring for the patient but also managing the stress of caregiving.11, 46 
The federal and state programs that fund long-term care services all have eligibility 
criteria based on age and the presence of particular diseases and conditions.  These eligibility 
criteria create major categories of people able to receive services: (a) elderly; (b) people with 
chronic physical diseases/conditions; (c) people with mental illness; (d) people with mental 
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 retardation or other developmental disabilities; (e) people with human immunodeficiency 
syndrome; and finally (f) children with chronic illnesses and special health care needs.48  Many 
of these programs that once used medical criteria as eligibility requirements are also using 
functional limitations instead or in addition to medical criteria.11, 48 
State governments play a key role in long-term care.  State governments are responsible 
for not only matching federal funds for Medicaid long-term care programs, but also licensure and 
regulation of providers, establishment of benefit criteria and application processes, and an array 
of regulations and tax incentives affecting the many community services.49, 57-59  State 
governments adopt and actualize their policies in response to federal mandates or guidelines.  
However, states have flexibility and are permitted to exceed federal minimum requirements and 
to alter their programs as they deem necessary.  There are many positive and negative effects of 
states’ ability adopt policies.  The wide range of benefits implies that federal requirements could 
be raised to reduce inequality.49, 57-59 
There is agreement among advocates, experts on Alzheimer’s disease and policy makers 
that Alzheimer’s disease patients should receive long-term care benefits.49 The dilemma amongst 
these groups is in regards to what criteria should be used to identify their eligibility.  Activities of 
daily living (ADLs) are the criteria most assume should be and will be used.  The question 
remains as to how many of these ADLs are needed to meet the criteria, which ADLs should be 
included in this criteria and the threshold for decline in cognitive function and so on.49, 57-59  
Criteria are the first step in this process.  The next will be to determine the level of benefits, type, 
amount and duration based on the eligibility criteria.  There is variance within and across states 
in the implementation process.  States have scoring systems, which assign weights to risk factors 
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 while others assign dollar allocations based on these scores.  Some states processes are based 
solely on clinical assessment.49 
Medicaid expenditures are focused on nursing homes, accounting for the majority of its 
spending.  Nevertheless, home health care services in states have increased in Medicaid spending 
from 10.8% in 1987 to 24% in 1997.12, 49, 55  Total expenditures for home health care in 2004 
were $71.1 billion for freestanding agencies.60  Medicare paid 27%, Medicaid and other public 
funds paid 55%, private insurance and other private sources paid 11% and out-of-pocket costs 
were 7%.60 (Figure 3)60  It is estimated that Medicaid expenditures in 2001 will more than double 
by the year 2018 due to the aging population, rise in care costs, and general inflation.12, 49, 55  
States provide home health services to individuals who are eligible for nursing facility services.  
These services include intermittent or part-time nursing services provided by home health 
agencies; registered nurses when there is no local home health agency; home health aides and 
medical supplies and appliances for home use.61]   In addition, personal care services are an 
option separate from home health care that can be offered under state Medicaid programs.  
Medical necessity or utilization control procedures are limits that can be placed on services under 
the Medicaid program.  However, the Medicare statute and the regulations on Medicaid home 
health services enforce stringent requirements.12, 49, 55 
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Figure 3.   Funding of home health care 
4.1. MEDICARE 
Medicare is a federal health insurance program run by the Centers for Medicare and 
Medicaid, a federal agency part of the U.S. Department of Health and Human Services. This 
program is for people 65 years and older, some people with disabilities under the age of 65 and 
people with End-Stage Renal Disease.57, 62   Medicare is composed of four parts.57  Part A covers 
hospital insurance, which most of those eligible for Medicare are not responsible for payment.  
Part B comprises medical insurance, for which those eligible are responsible for a monthly 
payment.57, 62  Part C provides for Medicare Advantage plans such as HMOs and PPOs.  Finally, 
Part D encompasses the prescription drug coverage.57  Additionally, those recipients determined 
disabled under Social Security Disability are automatically eligible for Medicare.  Social 
Security will be discussed in the following sections. 
Medicare Part A provides for inpatient care in hospitals, which includes critical access 
hospitals (small facilities that give limited outpatient and inpatient services to people in rural 
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 areas), skilled nursing facilities (not custodial or long-term care), hospice care and home health 
care.  Medicare Part A typically covers without having to pay a monthly payment, such as a 
premium.  In addition, at the age of 65, most people receive Part A automatically.  Receipt of 
Part A is without the responsibility for a premium and automatically at age 65 due in fact that the 
recipient or their spouse has paid Medicare taxes while they worked.57, 62  Furthermore, if you do 
not automatically receive this benefit premium free, there is the opportunity to be able to 
purchase it.  Those who may qualify to purchase this benefit for a premium include the recipient 
and their spouse who are not entitled to Social Security because they did not work or pay 
appropriate Medicare taxes while they were employed and are age 65 and older.  Additionally, a 
recipient who is disabled but no longer receives the premium-free Part A due to their return to 
work are may qualify to purchase this benefit.62 
Medicare Part B, which is optional, includes medical services such as doctors’ services, 
outpatient care, and other medical services not covered by Part A.  Part B provides assistance in 
the cost of medical services and items that are medically necessary. In addition, some 
preventative services are covered.57, 62  These preventive services include but are not limited to a 
one-time “welcome to Medicare” physical examination, bone mass measurement, flu and 
pneumococcal shots, cardiovascular screening, cancer screenings, diabetes screenings.57  The 
premium for Part B in 2007 is $93.50 per month.  However, premiums are based upon income 
and may be higher for certain individuals.  For those whose premium may be higher they include 
a recipient filing as single on an individual tax return with an annual income greater than 
$80,000 or recipients filing as married on a joint tax return with an annual income greater than 
$160,000.  Furthermore, these amounts fluctuate each year.57  
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 Medicare Part A and B do not cover all medical needs.  Cosmetic surgery, health care 
while traveling outside of the United States with limited exceptions, hearing aids, most hearing 
exams, long-term care such as nursing homes, most eyeglasses are just a few medial needs not 
covered under these sections.57  However, they may be covered under Medicare Advantage Plans 
(Part C). 
Part C or Medicare Advantage Plans are optional health plans offered by private 
insurance companies and approved by Medicare.  These plans provide all of Part A and Part B 
coverage, and must cover medically necessary services.  Part C encompasses extra benefits and 
may include Part D drug coverage.  Plus, plan doctors must been seen and certain hospitals must 
provide the covered services.  Typically, a monthly premium is paid in addition to the premium 
for Part B.  The costs will vary by pan and services utilized.57 
Part D is the prescription drug coverage offered to all recipients with Medicare.  Part D 
coverage provides protection for people who have very high drug costs or from unexpected 
prescription drug bills in the future.  Additionally, it provides greater access to drugs that are 
used to prevent complications of diseases and maintaining a good health status.  Part D is 
optional, run by insurance companies and other private companies and are approved by 
Medicare.  Again, a monthly premium is paid.  Decision not to enroll in this plan upon initial 
eligibility may result in a penalty if the decision is made to join later.  Limited income and 
resources may qualify a recipient for assistance in paying Part D costs.57 
Part D covers both brand-name and generic prescription drugs.  All Medicare recipients 
are eligible for this coverage regardless of income and status, health status, or current 
prescription expenses.  There are two ways to get the Medicare Part D prescription drug plan.  
The recipient may join the Medicare prescription drug plan, a Medicare Advantage Plan, or other 
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 Medicare Health Plan that offers drug coverage.  In addition to the monthly premium and like 
other insurance plans, there is a yearly deductible, which varies by plan.  Furthermore, the 
recipient will be responsible for costs of prescriptions including copayments and coinsurances.  
Moreover, recipients will be responsible for the first $250 in drug expenses, and then will pay, 
on average, a 25 percent coinsurance until they reach the benefit limit ($2,250 in 2006). Once 
they reach the benefit limit, they will face a gap in coverage in which they will pay 100 percent 
of their drug costs up to $5,100 in total drug spending (equal to $3,600 in out-of-pocket 
spending). Medicare will then pay 95 percent of drug costs above that amount. 63
4.2. MEDICAID 
Medicaid is a federally established program administered through each state.  This 
program provides benefits for medical to low-income people.  Under the federal guidelines for 
this program, each state must include certain types of individuals and groups.  There are three 
eligibility groups at the state level:  categorically needed, medically needed, or special groups.  
For the purposes here, concentration is placed upon the medically needed.64, 65  
The medically needed are defined as people who have too much money, which includes 
resources such as savings.  Not all states provide for the medically needed, but if the do they 
must include pregnant women through a 60-day postpartum period, children under age 18, 
certain newborns for one year, and certain protected blind persons.  In addition, states may also 
opt to provide aged persons (age 65 years and older), disabled persons (disability has been 
determined using either the Social Security Insurance program standards or state standards), and 
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 persons who would be eligible if not enrolled in a health maintenance organization.  The state of 
Pennsylvania does provide for the medically needed.64, 65 
State programs are required at a minimum to provide the following services:  inpatient 
and outpatient hospital services; physician, midwife and certified nurse practitioner services; 
laboratory and x-ray services; nursing home and home health care for individuals age 21 and 
older; early and periodic screening, diagnosis and treatment (EPSDT) for children under the age 
of 21; family planning services and supplies; and finally rural health clinic/federally qualified 
health center services.  States are required at a minimum to provide home health services to 
recipients who are eligible to receive nursing facility services under the state’s Medicaid plan.  
The elderly/disabled are automatically eligible for Medicaid based on eligibility for Social 
Security Insurance.64  However, there are established resource limits.  For one person the limit is 
$2000; for two people it is $3000.58, 64, 65  For those individuals aged 65 or older, disabled or 
blind and are not receiving Social Security Insurance, there are income limits.  For one person 
the limit is $250, for two people it is $1000.58  For the medically needy only limits the income 
limit is $2400 for one person, $3200 for two people and $300 for each additional person. 58 
An extension to Medicaid is waivers, provided through the Centers for Medicare and 
Medicaid Services, to allow states the opportunity to provide home and community services.  
Medicare waivers come in various forms and vary by state.  Pennsylvania offers 11 waivers that 
provide benefits to many different populations including those aged three and under and the 
elderly. The Managed Care/Freedom of Choice Waivers [1915(b)] is requested to administer 
programs impacting the delivery system of some or all of the recipients eligible for Medicaid by 
state.  These include mandatory enrollment of beneficiaries into manage care programs and 
developing a delivery system for specialty care.  This waiver program is not required to be 
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 implemented statewide.  In addition, it may not be used to broaden eligibility requirements to 
include those ineligible applicants under the current, approved state plan.  Furthermore, it is not 
permitted to impact beneficiary access, quality of care services and must be cost affective.66  The 
HCBS waiver [1915(c)] permits states to offer an unlimited array of services to consumers.  
Traditional medical services, such as dental services, skilled nursing services, and non-medical 
services, such as respite, case management, environment modifications are supplied by this 
waiver.  Furthermore, family and friends of the recipient are eligible to be providers of the 
waiver service once provider qualifications are met.66  Finally, a state may choose to employ 
waivers, 1915(b) and 1915(c) to administer a continuum of services to the disabled and/or 
elderly populations.  Subsequently, the 1915(b) authority to limit freedom of choice and 1915(c) 
authority to target eligibility and provides home and community-based services, states are not 
able to offer long-term care services in a managed care environment of use a limited pool of 
providers.66 
Two of the waivers the state of Pennsylvania offer are the ‘Pennsylvania Department of 
Aging (PDA) waiver’ and the ‘Long Term Care Capitated Assistance Program (LTCCAP)’.  The 
PDA waiver provides home and community based services to eligible persons age 60 or older 
that are clinically eligible for nursing facility care.  Eligibility criteria for the PDA waiver 
include individuals age 60 or older, income limit must be equal or less than 300% of the Federal 
Benefit Rate and resources are $2000 or less.  In addition, the individual must have a level of 
care for Skilled Nursing Facility.  Some of the services available under this waiver include but 
are not limited to personal care services, home health aides, older adult daily living centers, 
specialized medical equipment and supplies and transportation services.67 The LTCCAP waiver 
program is a health care and supportive services program designed as an alternative to nursing 
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 facility care for qualified older Pennsylvanians.  There are two sets of criteria for eligibility.  The 
financial eligibility requires a $2000 resource limit and an income limit 300% the Federal 
Benefit Rate.  The functional eligibility requires individuals aged 60 years and older and be 
eligible for nursing facility services.  Services for this waiver include but are not limited to in-
home supportive care, personal care, pharmacy services and medications, adult day health 
services, and nursing facility services.  The individual must be residing at home at the time of 
enrollment, in a domiciliary care home with prior approval or a long term nursing facility when 
needed to receive this benefit.  Eligible programs are currently located in Allegheny County, 
Beaver County and certain areas of Philadelphia County. 67 
4.3. SOCIAL SECURITY DISABILITY 
Social Security Disability is administered through Social Security Administration with 
the intent to provide benefits to those people who are unable to work due to a medical illness 
which is expected to last a minimum of a year or result in death.  Earning requirements have 
been set for those with a medical disability to receive this benefit.  Benefit recipients must meet 
two separate earnings tests.  The first earnings test is based on the recipient’s age at the time they 
became disabled.  The second earnings test is to show that the recipient has worked for a 
mandatory period to be eligible to receive Social Security.59 
Upon application for Social Security Disability, earnings test must first be met.  If the 
applicant meets these requirements then their application is reviewed by the Disability 
Determination Office in their home state.  It is the state office that then determines receipt of 
benefit.  The process of decision includes disclosure of health status by one’s own attending 
doctor.  The state agency needs to know the following:  a) What your medical condition is, b) 
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 When your medical condition began, c) How your medical condition limits your activities, d) 
What the medical tests have shown, and d) What treatment you have received.  Additional 
information may also be needed such as one’s ability to perform work-related activities.59 
The Disability Determination Office in the applicant’s home state proceeds through a five 
step process to make the final determination of disability status.59  These steps include:  a) Are 
you working, b) Is your medical condition ‘severe’, c) Is your medical condition on the list of 
impairments, d) Can you do the work you did before, and e) Can you do any other type of 
work.59  The agency reviews the applicant’s work status.  By doing so, if the applicant is 
working, the agency will then assess the amount of money being earned a month.  There is a 
limit as to the amount a disabled person is able to earn.  If the applicant is earning more than the 
limit, the agency will determine the applicant is not disabled.  However, if the applicant does not 
make more than this limit or is not working, then the agency moves to the next step and reviews 
the medical records. Upon reviewing medical records, the agency seeks to determine whether 
one’s medical condition limits or impairs one’s ability to perform basic work responsibilities.  If 
the agency determines that the medical condition is severe, the agency will progress to the next 
step.  The agency has a List of Impairments describing medical conditions defined as severe 
automatically labeling the applicant as disabled.  If the applicant’s medical condition is not 
provided on this list, then the agency will compare the applicant’s medical condition to those on 
the list for its severity.  Once it is determined that the medical condition meets the severity 
criteria, the agency will then consider whether the medical condition prohibits the applicant from 
performing those work responsibilities they performed previously.  When the agency determines 
that the applicant is unable to perform these same responsibilities, it will then consider whether 
the applicant can perform other work responsibilities.  If the applicant is unable to do so, the 
 32 
 agency finally decides that the applicant is disabled.59  Once an individual has been determined 
disabled, they are automatically eligible for Medicare benefits. 
4.4. PACE 
The Program for All Inclusive Care for the Elderly (PACE) is a unique program available 
for both Medicare and Medicaid recipients.  The program was designed to assist older people, 
who are frail and meet their State's standards for nursing home care.  Benefits to the recipients 
include comprehensive medical and social services available through adult day health centers, 
home, and/or inpatient facilities.  The comprehensive service package permits the elderly to 
continue living at home while receiving services, rather than be placed in a nursing care facility.  
Assessment is conducted by a team of doctors, nurses, and other health professionals who 
determine participant needs, develop care plans, and deliver all services, which are integrated 
into a complete health care plan.  PACE is available only in States, which have chosen to offer 
PACE under Medicaid.68-70 
Eligibility for PACE includes age criteria of 55 years of age and older and residence 
within the PACE service area.  Additionally, the participant must be screened by a team of 
doctors, nurses, and other health professionals and determined to meet the state's nursing facility 
level of care.  Finally, the participant, at the time of enrollment, must be able to safely live in the 
community setting.68-70 
This program was modeled after the On Lok Senior Health Program in San Francisco, 
California.  The program model was then tested through the Centers for Medicare and Medicaid 
Services demonstration projects beginning in the mid-1980s.  This model addresses the needs of 
long-term care recipients, providers, and payers.  Capitated financing permits the providers to 
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 deliver participants all services needed rather than limiting them to the services reimbursable by 
Medicare and Medicaid fee-for service systems.  68-70 
There are nineteen states who participate in the PACE program.  In the state of 
Pennsylvania, specifically, there are four providers.  These providers are located in Philadelphia 
(2) and Pittsburgh (2).  More specifically, Pittsburgh has two established programs, Community 
LIFE and LIFE-Pittsburgh Inc.  The eligibility criteria for these facilities are as follows:  at least 
55 years of age and eligible for Medicaid or have the ability to private pay.  In addition, they 
must have health related problems that make it difficult to manage their own needs 
independently at home, qualify for nursing home level of care, and be able to live safely in the 
community with the services provided.  The recipient of this benefit must, however, reside in 
specific zip codes.68-70 These facilities provide a range of services that include but are not limited 
to day center services, adult day care, meals, and transportation.  Additionally, a medical suite 
provides, but is not limited to, prescription services, primary medical care, nursing and 
laboratory tests and procedures.  The in-home services include skilled nursing, personal care and 
chore services.  Outpatient services provided through this program include specialist services, 
medical specialists, audiology/hearing, dentistry, optometry and podiatry.  The inpatient services 
provide through this program include hospital, nursing home and inpatient services.68-70 
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 5. STUDY RESULTS 
The results and analysis from these two exemplar cases are presented as an integration of 
excerpt and social policy analysis.  This integration of case data and commentary is a common 
approach in qualitative research.71  A comparative case study of two community-dwelling 
Alzheimer’s disease patients and their family caregivers focusing on social policy specifically 
eligibility, availability and equality of resources are presented.  Comparison and analysis of these 
two cases are used to illustrate and further examine details of social policy in the context of the 
lives of real families experienceing AD.  The late-onset AD patient, referred to from here on as 
“Robert”, is a 76 year old Caucasian man.  Robert was married but has been widowed for nearly 
two years.  He is currently retired.  Robert is the father of four adult children; two sons and his 
two daughters who undertake primary caregiving responsibilities.  He owns his own home which 
he visits daily with a male aide.  He resides with his two daughters residing half of each week 
with each.  Robert receives Medicare benefits, Social Security Insurance (SSI) and a pension.  
His insurance covers all costs of medication and health care. 
The early-onset AD patient, referred to from here on as “Lucy”, is a 51 year old 
Caucasian woman.  She has been married for twenty-seven years and continues to live with her 
husband and daughter in their home.  Lucy is the mother of two children, a son and daughter.  
Lucy recieves Social Security Disability and Medicare benefits as a result of a psychiatric 
disability and private health insurance through her husband.  Her insurance pays for the majority 
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 of her medications for which there are copays.  In addition, most of the costs for her health care 
is although there is a copay. 
In-depth analysis and comparison of two case studies reveals a pathway of social care 
needs among community dwelling Alzheimer’s disease patients and their family caregivers.  The 
objective of the family caregiver is to maintain community dwelling status for the patient.  The 
caregiver strives to achieve this through a process of accessing social services, cultivating social 
support networks, maintaining continuity of care and managing the health care needs beyond the 
patient’s diagnosis of Alzheimer’s disease.  Achieving this objective begins at the diagnosis of 
Alzheimer’s disease with alternation between these aims. (See Figure 4)  However, maintaining 
community dwelling status of the patient can be a fluctuating process.  There are barriers and 
setbacks to achieving a stable community dwelling status for the patient such as service 
eligibility criteria, proximity to services (location) and/or a lack of social supports such as family 
and friends resulting in the need to readdress other areas in the process. 
The family caregiver’s focus of attaining a stable community dwelling status for the 
patient is the patient and the patient’s care.  As one family caregiver stated, “I mean it, none of 
this is about me… Um, you know it’s about them and it’s about him and whatever it takes to 
make it easier for him is what I think we need to do, you know?”  An aspect of preserving 
community dwelling status of the patient is facilitating the ability of the patient to remain living 
in the community setting.  There is a high tolerance and patience on the part of these family 
caregivers in addition to a sense of filial duty and obligation. 
[Daughter, LOD] “Or if he would get to the point where he was smearing stuff all 
over the walls.  Then, that might be something that I don’t think is an option for 
my children to witness.  If that’s not it, there’s no option, he stays…You know he 
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 just stays with us.  You know?  That’s the way we all look at it anyway.  None of 
us are faltering at all with him, ‘cause he, you, you know.  He worked two jobs 
almost all his life to make sure we ate.  You know, the least we can do is take care 
of him.  You know ... make sure he’s safe.”   
 
 
Figure 4.   Pathway to Social Care Needs for Community Dwelling Alzheimer’s disease 
Patients and their Family Caregivers 
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 5.1. ACCESS TO SOCIAL SERVICES 
On the route to maintaining community dwelling status of the patient, a primary step for 
the family members is to access social services for both financial and social support.  The social 
support that a family caregiver and patient receive comes in the form of support groups, day care, 
respite care, and financial assistance.  Accessing these services however is dependent upon 
eligibility criteria and location.  Eligibility criteria for social services are dictated by the age of 
the recipient, most typically 65 years and older.  This can create frustration for the families of 
patients diagnosed with early-onset Alzheimer’s disease.   
 
[Spouse, EOD] “Nothing kicks until you’re in your 60’s. There’s nothing. So 
between that and the fact that she can’t qualify for the trials because she doesn’t 
do well enough on the tasks or she’s not old enough, again, got to be 56 for most 
of them, it’s frustrating.  …it’s so frustrating for me because number one (in a 
rural county in Southwestern Pennsylvania) there are no support services around 
because she’s 51.”   
 
[Spouse, EOD] “There’s been no help here in town at all. I mean, you know, I 
went to aging services, we, they have a daycare center over there, we thought 
maybe she could go over there and just pretend she’s working. They didn’t want 
to hear it. Maybe it’s the liability issue, probably. You know, but there’s no adult 
daycare in town, there used to be a couple Alzheimer’s daycare units, they 
stopped it. There’s a big Presbyterian home here in town. She was so bad in 
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 December; her parents were insisting we were going to put her in the 
Presbyterian home. And we went out there and I went to the Alzheimer’s unit, and 
I said I don’t want to do this. I said, these people are all in their 70s…”  
 
Access to services for those patients 65 years and older is much easier and more readily 
available.  The late-onset patient in this study was able to receive several types of social services 
which included an adult day care, in-home caregiver (male aide), and help with medication 
prescription which enables the patient to remain living in the community setting.  Robert, a late-
onset AD patient, began using Adult Day Services since his wife was in such ill health, and has 
had experience with Adult Day Care for a while.  This is not new to him.  He lives 3 ½ days with 
(younger daughter) and 3 ½ days with (eldest daughter).  Every other month the daughters 
“switch” and alternate weekends; otherwise one family never seems to get a weekend to go to 
movies or anything, which (eldest daughter) children had begun to complain about, never being 
able to go and do things on the weekends when “Pap Pap” was there.  Each day upon leaving the 
Adult Day Care Center, Robert goes to his own residence in a Borough (in an urban county in 
Southwestern Pennsylvania) from about 1pm to approx 430pm when one of the daughters picks 
him up to go to their home.  During this time period in his own residence, he is attended by a 
male aide from the Adult Day Care Center.  
 
[Daughter, LOD] “We share custody; we have 3 ½ days a week. He’s here from 
Sunday at 10 in the morning till Thursday morning and I get him on the van, and 
she picks him up from his house with the caregiver on the van Thursday night and 
keeps him till Sunday morning. We do that, we rotate that every month. Every 
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 other month, one family member’s got the weekends off and the other family 
doesn’t. My husband’s a city officer ... for two years we did all weekends and the 
kids were going bonkers. You know, cause they didn’t have any weekend time, 
cause we had Pappy. You know Pappy had to be home for his nap and you know, 
this that and the other thing, so we couldn’t do that. So anyway, it works out 
better that way. So, we share with her.”   
 
[Daughter, LOD] “…The daycare because it’s like the all inclusive medical clinic 
thing. And we just said “you know what, we’re having some swallowing issues 
here.  What do you have chewable, what do you have liquid?”  And Anna Marie, 
his nurse, came back and said, “I can get the potassium in liquid,” she said she 
could get the Celexa in liquid. Um, but right now, we’re not havin’ a problem 
with the morning pills.”   
 
In contrast, the parents of the Lucy, the early-onset patient, pay out of pocket for an 
outside caregiver.  Lucy’s husband is unable to afford this service. Although Lucy’s parents can 
assist financially, it is not always the case and represents juxtaposition for the sandwich 
generation caregiver who is not only caring for his wife, but also has a daughter finishing 
college. 
 
[Spouse, EOD] “I got a list of aging services with caregivers but you call 
(inaudible) and they’re all busy. So I put an ad in the paper and I was very 
fortunate, this older lady, actually her grandson was one of my son’s good friends 
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 in elementary school but um she had been a caregiver for a state senator’s wife 
here for years who had Alzheimer’s, and um..  …had experience, yea. And and 
these people, I figure she had good (inaudible) with these people. And um I 
interviewed a younger gal in her 40s who had three teenage boys; most of her 
experience was not in a home situation it was in a personal care home. …I find 
myself getting a little resentful and start pleading, I appreciate your financial help 
and everything that you give us, and the kids and everything, but, but we can get 
by without that.” 
 
Interestingly, the spouse of the early-onset patient is savvy.  Although his wife qualifies 
for no financial or social service supports, he has explored other alternatives.  These alternatives 
include qualification for clinical research trials as a means of accessing medications and services.  
The early-onset patient is enrolled in a double-blind placebo controlled trial sponsored by a drug 
company.  Unfortunately, one of the main barriers of clinical research trials is age.   
 
[Spouse, EOD] “So between that and the fact that she can’t qualify for the trials 
because she doesn’t do well enough on the tasks or she’s not old enough, again, 
got to be 56 for most of them, it’s frustrating. I unloaded on this guy, I said I don’t 
understand it I said to me she’s in perfect health other than the Alzheimer’s….”   
5.2. BUILDING A SOCIAL SUPPORT NETWORK 
An essential element to realizing a stable community dwelling status for the patient is the 
family caregiver’s ability to build a social support network.  This network includes family, 
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 friends, and social groups that provide emotional support, physical assistance and respite.  An 
element to building social support networks needs considered.  For families of a late-onset 
Alzheimer’s disease patient, elderly spouses, adult children and grandchildren become members 
of the social support network.  For families of an early-onset Alzheimer’s disease patient, aging 
parents, spouses and dependent children are members of the network.  The dynamic and potential 
types of support in these differing networks results because of the age of onset for the disease. 
The adult caregiving daughter of the late-onset patient described the support network in 
place for this family.  She was asked if she had an emergency, and couldn’t be here, couldn’t 
give his medicine, what kind of back-up plan does she have.  The following quotation is a 
response to this question. 
 
[Daughter, LOD] “Well my husband normally is home.  Um, I have a cousin who 
lives next door.  Like say for instance, (caregiver’s husband) has guitar lessons 
on Wednesday night or is out of town, he comes over and he’s there as a back-up.  
We have a lot of good family.  Yeah, and my aunt... (can be instructed in the 
medication routine)  Yeah, yeah. And, and I think that’s very helpful with the pills 
being put out, or whatever, too, I mean, my husband watches the routine, my aunt 
knows the routine,  you know, it’s better to have more than one person know the 
routine. No doubt. But I think if something would seriously happen, like, God 
forbid, I got in a car accident or something, (sister who shares caregiving duties) 
would immediately take over.  And same for me.  You know, so we have each 
other to back us up.” 
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 In comparison, the spouse caregiver of the early-onset patient has difficultly establishing 
a social support network.  Family support appears to be limited as does support by friends.  In 
addition, this family caregiver struggles within this small network available to them.  This couple 
has two adult children; a son working in California and the daughter, a fine arts major, went to 
Europe for the summer.  The son is quite accomplished.  “Everything he touches turns to gold.”  
The husband is unhappy about the daughter’s trip to Europe because he would rather have her 
home this summer to be with her mother.  Moreover, the daughter is having difficulty handling 
the changes in her mother’s condition and functional ability.  The son, on the other hand, is 
extremely good and patient with his mother.  The patient’s siblings, two brothers, have both died 
at early ages due to an accident and cancer.  The spouse of the early-onset patient has a small and 
limited network.  Outside of his family, there is the in-home caregiver that stays with the patient 
three days a week and also a wife-nurse who assists with her care when this spouse takes trips to 
perform in a Civil War band.  This spouse has a friend whose wife is a nurse and volunteers to 
assist with the care of the EOD on the Civil War band trips. 
In contrast, the family of the late-onset patient has support, in addition to their family and 
friends, of those who care for their elderly father.  This family has established strong connections 
with the outside caregivers; there is a line of communication and trust between all involved in the 
caring of this patient.   
 
[Daughter, LOD] “I can actually get his bag and show you, ‘cause we, we um, 
have a little bag, um, that goes to and from the center that will [we use to] 
communicate.  This is a little med bag (sound of bag unzipping) and all his meds 
come in here once a month.  He, it’s this thing here, (showing the researcher the 
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 notebook-journal) and it was happening once... Well, when something’s goin’ on, 
like they checked his ears and here’s today.  (Reading) “Saw Mr. S. today, and he 
has an irritation in both external ear canals, please apply ...” (Continuing to 
read) “Also took new ear impressions today and changed the tubing ...” oh, his 
hearing aids were broken…  (continuing to read-backward in time) But, so you’ll 
see “had my flu shot today” But I charted it when he was having seizures [sound 
of pages turning]…‘cause we were tryin’ to figure out, they were startin’ to come 
more frequent, at least they ... they were happening once every three months.  
Here, April second was the first one, June couldn’t pinpoint a day, August 29th, 
then by October into November he had like nine.  And we were the only ones 
seein’ them (seizures) at first, then the Center had seen it.  Then the caregiver at 
his house while we were still working had seen it.  Then we started getting’ to the 
nitty-gritty a little bit as to what’s goin’ on.  Dr. M thought it was cardiac, and 
then, you know, they did the 24-hour monitor on him, and ... stuff like that.” 
 
[Spouse, EOD] “We were in Virginia for one of my scheduled appearances and 
walking through the hotel lobby, (the patient) became uncontrollable and 
paranoid.  We finally got her to her room and she settled down.  She felt someone 
was after her and going to kill her.  She was extremely upset.  Many of the other 
men playing in the band have wives and they have pitched in to assist with (the 
patient) on these trips. One person in the band has a wife who is a nurse and she 
has been very good to (the patient).  However, there is a trip coming up very soon 
and I will not take her on this trip because the nurse-wife will not be there.”   
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 [Spouse, EOD] “I have one group here in town who has offered me help at all 
and it’s called CareNet and it’s put together by the churches.  Most of the help 
they give is like volunteer services for 2 or 3 hours. Which is not what I needed 
you know.  But I do meet with one of the gals there (referring to CareNet) who is 
a nurse, really nice lady, we have coffee every once in a while and just chat. She 
got me to go to an Alzheimer’s support group at the hospital and I went. It was 
kind of interesting. Except nobody there is in my situation, they’re all there with 
parents. And and they’re older. They’re not keeping up on any research…Like 
somebody said you know, in Pittsburgh you have more access to services. It’s 
really frustrating. They’re diagnosing younger and younger.” 
5.3. MAINTAINING CONTINUITY OF CARE 
‘Continuity of care’ becomes an aim for the family caregivers to achieve.  For those 
families who are unable to succeed in ‘accessing social services’ and ‘building a social support 
network, continuity of care may not be attainable.  Accessing social services and cultivating a 
social support network are essential conditions for attaining continuity of care.  Necessary 
elements in continuity of care are communication between caregivers, normalization or 
routinization of care, and planning for emergencies.  The caregiver of the late-onset patient 
provides the following description of their weekly routine. 
 
[Daughter, LOD] “The Community Life van comes for him and at that point, he is 
just taking his vitamins, and they pull up. So it’s really repetitive timing, 
especially during the week with how we do things. And I think that is important 
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 because it’s routine. You know, it’s that routine thing again. And it’s better 
because of his medication to be around the same time, I don’t really think a 
couple of hours makes a difference in the mornings that he sleeps in,…but 
nothings really different on the weekend, um as opposed to the weekdays. Yea. 
Pretty much the same.”   
 
In addition, these caregivers stress the importance of routine and the need to adjust 
behaviors to maintain the routine. 
 
[Daughter, LOD] “She’s gonna pick you up.”  So everybody’s in a routine and we 
just share that with home care, and they follow through real nicely, …We have 
really been blessed with the situation.”   
 
Chaos can erupt when continuity of care is not established.  The importance of the routine 
of schedules was not seen in the family of the early-onset patient.  This family caregiver, with a 
limited social support network and access to social services, struggles to manage his wife’s care.  
In the following passage, the family caregiver describes the chaos that ensued when the patient’s 
parents provided care to her.  Considering the patient’s parents do not provide consistent care to 
her, they are not properly prepared to provide her care. 
 
[Spouse, EOD] “Like we had a problem last weekend. She stayed with her 
parents and they came on Saturday afternoon to let the dog out. I had a job down 
in Washington I had to leave at 5:30 in the morning and didn’t get back until 11 
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 so she stayed with her parents and they came in the middle of the afternoon and 
the dog had pooped in the house. First time it’s ever happened.  Well her mother 
and father got REALLY upset apparently. And swatted the dog and and (the 
patient) got REALLY upset.”   
 
In achieving ‘continuity of care’, families emphasize the importance of communication.  
Communication is essential to pass information to all caregivers involved, to control the 
behaviors and actions of those involved in the day to day care, and to achieve normalcy amongst 
the caregivers. 
 
[Daughter, LOD] “Oh yeah, we make sure that if something’s not working, that 
we tell the other person, and then 90% of the time we realize it.  Both of us have 
seen the same thing…And I’ll say, “Well this works for me,” and then she says, 
“Okay, I’ll try it.”  Or I’ll say, “He’s startin’ to do this,” she says, “Yeah, I know 
he did it for me the last two days, try this.”  And we talk everyday just about, 
about dad.  So, he’s spoiled ... (laughing)” 
 
[Daughter, LOD] “The internet, and Community Life.  Yea, I do get information 
from them (referring to Community Life) although there’s a lot of times that I’ve 
given them information, or you know, “Oh, I read this, what do you think about 
this” and then they’ll run it past the doctor and um, she’s pretty busy, so you 
almost have to call again, like if you feel real strong about something, but other 
than that, they’re extremely good. “ 
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 The final component of continuity of care is planning for emergencies.  If the family 
caregiver’s social support is not solid, they struggle to maintain normalcy in their own lives.  In 
addition, with a small or limited social support network, the establishment of continuity of care is 
a delicate and conscious process. 
 
[Spouse, EOD] “The paid caregiver will come anytime we need her.  She’s real 
flexible. Right now we’re doing 21 hours a week. If I need her to stay on a 
weekend with (the patient) she will. If I need an overnight, she will stay. She’s 
real flexible that way. …It is, and that’s why I took her, that’s one of the reasons I 
took her over the younger lady who has teenage kids.”   
5.4. MANAGEMENT OF HEALTH CARE NEEDS BEYOND AD 
An important component for the family in achieving a stable community dwelling status 
for the patient is to begin managing the health care needs beyond the patient’s diagnosis of AD.  
The family caregivers of the late-onset patient have been able to succeed in the management of 
the diagnoses of AD.  They now can place more of their focus onto the patient’s 
(other/additional) health problems.  The late-onset family provides an illustration of how they are 
able to manage Robert’s health beyond the AD. 
 
[Daughter, LOD] “But he does see his... you see your cardiologist on Wednesday, 
and I’m gonna pick him up at the Center and take him there, um, because 
(laughing at something PT does) knock it off.  They think it’s cardiac. I think it’s 
uh, I mean I’ve worked with people with handicaps for 12 years.  … Yea, he 
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 trembles, he goes (pause) you know… This was before; this was why we tried him 
on the Dilantin, cause I just think it’s neurological. They put him on uh, they 
changed his Cardizem and put him on those two heart pills and he’s still having 
the spells so we got him on the Dilantin and we didn’t see one since we’ve taken 
him off either. So I’m, I know it’s neurological, I mean he needs a cardiac 
appointment anyway. He had a quintuple bypass about 16 years ago, so he needs 
a cardiology appointment anyway, but I don’t believe that it’s cardiac, in my own 
mind anyway…I’ve seen too many seizures (laughing) to know that it’s… you 
know, but uh…”   
 
Unfortunately, the family caregiver of the early-onset patient has not been able to achieve this 
component and therefore, he continues to deal with the diagnosis of AD. 
 
[Spouse, EOD] “I mean, personality wise, most of the time she is just fine and you 
know.  I notice that later in the evenings she seems to get real confused later in 
the evenings.  She can’t do a lot of tasks now as far as her memory stuff and that.  
But in the evenings she gets almost nonfunctional sometimes.  Like last night we 
had a phone call and she was taking the portable phone and I asked her to bring 
me the phone.  She tried to bring the whole unit out.”   
 
[Spouse, EOD] “…yea, I mean she was having a hard time with things, she 
couldn’t even remember (inaudible - anything).  She can have 3 pill bottles in 
front of her and take one and not remember she took it…short term memory is 
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 awful…long term memory is great. And I don’t know whether that’s typical or 
not. I think it is probably. We ran into some people in town at dinner a few weeks 
ago and that we’d just seen on a social basis, they’re older, they’re from 
Blairsville, and and they were having dinner and Sue and their daughter, like 35 
years ago went to a church camp together. She asked them by name how the 
daughter was doing. It’s just amazing.”   
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 6. DISCUSSION 
This study documents and describes how family caregivers maneuver through a system to 
provide for their family member.  The data provides two case exemplars which highlight the 
factors to achieving a stable community dwelling status for the patient.  The analysis identified 
and described how these essential components facilitate this process.  In addition to the elements, 
barriers and setbacks were identified.  The objective and its components provide insight into the 
caregiving process which may be key to social policy revision.   
Access to social services is a difficult hurdle.  Medicare, Medicaid and Social Security 
Disability Insurance have defined eligibility criteria.  And for those AD patient’s who fall below 
the age requirements, live in communities or do not meet economic requirements, these 
programs fall short.  These families struggle to achieve a stable community dwelling status for 
the patient.  They may explore additional outlets, such as research or extended family support, 
yet are likely to only receive minimal levels of support.  Because family caregivers of AD 
patients need to continue working, as demonstrated by all three family caregivers in the cases 
studied here, these social services are essential to cover informal costs formal caregivers, such as 
adult day centers or in-home caregivers.  These programs, Medicare, Medicaid, and Social 
Security Disability can afford family caregivers the ability to acquire this additional assistance.  
However, these policies are not available to patients and families of early-onset Alzheimer’s 
disease.  Informal cost associated with AD include incremental caregiver time required to assist 
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 the patient with activities of daily living (ADLs), instrumental activities of daily living (IADLs) 
and supervision for patient safety.13, 14 
These families cultivate their established social support networks by coordinating care 
with other members of the AD patient’s family, and enhancing their support networks with the 
formal caregivers, doctors, nurses, extended family and friends.  Social support networks that are 
well developed can have a positive affect on the life of the patient.72  They are able to do this by 
providing consistency, familiarity, normalcy.  It does not appear necessary to have a large social 
support network.  Most important is a social support network that is informed, consistent and 
communicative with each other.  In addition, the social support network must be trusted and 
reliable.72 
With the establishment of a strong social support network, continuity of care is fostered.  
As the social support network begins to work together, care becomes consistent.  For those 
diagnosed with early-onset AD, continuity of care may be a challenge.  It is difficult for families 
to accept such a diagnosis.  In addition, it becomes a challenge for the primary caregiver to rely 
upon family members and friends.  Therefore, the primary caregiver may have to resort to the 
assistance of outside caregiving services.  Another challenge facing AD patients and family 
caregivers when emergencies arrive and these outside caregivers are unavailable and they then 
must rely on those family and friends to assist with the patient’s care.  Families of late-onset 
patients may have an advantage to maintaining continuity of care due to the fact this disease is 
perceived as disease of the elderly, they are adults who have stability in their own lives and the 
patient is eligible for a variety of benefits.  The primary caregivers of late-onset patients may 
have an established social support network that can assist with the care of the AD patient.  If the 
primary caregiver has siblings they may be able to rely upon to assist with care.  This reflects the 
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 trend that primary caregivers tend to be the spouse of the patient, live with the patient and 
continue to work relying upon formal (outside) caregivers.11, 14 
Each patient and family does not necessarily achieve each component in the process.  
They may, in fact, fluctuate between these elements.  Much of this fluctuation is a result of the 
needs of the patient and caregiver.  At any given time in this process, the patient may need to 
have their medical conditions monitored for illnesses other than the Alzheimer’s disease.  The 
primary caregivers must address these issues as they arise.  It is a difficult balance for these 
patients and caregivers. 
The family caregiver may have a better opportunity to provide for their AD patient if they 
are eligible for all social services.  I suggest that for all patients with AD and their family 
caregivers to face this diagnosis on a level playing ground should be based upon diagnosis of 
disease instead.  Although it may be argued that this would place an ever increasing burden on 
the cost of benefits such as Medicare, Medicaid and Social Security Disability Insurance, I would 
argue it would not based on the shorter length of anticipated life expectance of early-onset 
patients than those with late-onset42, 43.  At this time, the early-onset patient are not eligible for 
Medicare, Medicaid and Social Security Disability Insurance.58, 59, 62  Although the early-onset 
patient in this case was receiving Medicare and Social Security Disability Insurance, the receipt 
of these benefits was due to a previous psychological disability and not her age or diagnosis of 
AD.  Furthermore, eligibility based upon diagnosis for early-onset patients and family caregivers 
would be beneficial in that families may be able to continue caring for the patient in the 
community.  
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 6.1. PUBLIC HEALTH SIGNIFICANCE 
Continuing to maintain care for Alzheimer’s disease patients in the community setting is 
of great significance to the field of public health.  Because those people diagnosed before the age 
of 65 face difficulties, financially and socially, altering the eligibility criteria for access to social 
services will aid in maintaining them in the community setting for longer periods of time. 
• Federal government agencies, such as Medicare, Medicaid, and Social Security 
Disability Insurance, need to view early-onset disease with the same perspective 
as late-onset Alzheimer’s disease, setting the precedent for state programs and 
allowing eligibility criteria to be based upon diagnosis. 
• State agencies who monitor these programs need to view those younger than 65 
with Alzheimer’s disease in the same perspective as those with late-onset AD and 
begin to alter eligibility criteria for these benefits. 
• Federal and state agencies should plan for additional sources of funding to enable 
the financial support to all persons diagnosed with Alzheimer’s disease, whether 
late-onset or early-onset. 
• Federal and state agencies should begin to discuss the impact the diagnosis has 
upon the health care system, specifically the fact that this population is expected 
to almost quadruple in size from 2001 to 2050. 
• Social support organizations should provide resources and information based 
upon the needs of both families of late-onset and early-onset patients. 
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 • Social support groups should provide counseling to early-onset families as a 
means to aid with coping, a result of a sometimes shocking and unbelievable 
diagnosis. 
Although the results of this study may not be transferable to all Alzheimer’s disease 
patients and their families, it provides insight into the struggles that patients and families may 
encounter as a part of the disease and accessing social care needs.  The information gathered here 
can be used as a beginning step into further research to study the needs of these patients and 
families.   In the end, this study adds to the body of knowledge regarding Alzheimer’s disease 
patients and their families social care needs by detailing the experience of accessing social 
services, cultivating social support networks, maintaining continuity of care, and managing 
health care needs beyond the diagnosis of AD. 
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